China Shineway Pharmaceutical Group Limited (FRA:C1S)

Germany · Delayed Price · Currency is EUR

0.8050

+0.0050 (0.62%)

Last updated: Oct 23, 2026, 3:25 PM CEST

Market Cap	625.78M -12.4%
Revenue (ttm)	343.25M -20.3%
Net Income	103.66M -2.9%
EPS	0.14 -2.3%
Shares Out	n/a
PE Ratio	5.76
Forward PE	6.19
Dividend	0.27 (33.26%)
Ex-Dividend Date	Oct 2, 2026

Volume	140
Open	0.8600
Previous Close	0.8000
Day's Range	0.8050 - 0.8600
52-Week Range	0.7950 - 1.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 2,656

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol C1S

Financial Performance

In 2025, FRA:C1S's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements